Simon Wildermuth

Simon Wildermuth

Auto-generated profile, based on publicly available information

Simon Wildermuth

Division of Radiology and Nuclear Medicine, Cantonal Hospital St. Gallen, St. Gallen, Switzerland

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2000 in Radiology
Verified
Journal Article
Closed access
WLWolfgang Luboldt
Wolfgang Luboldt
PBPeter Bauerfeind
Peter Bauerfeind
SWSimon Wildermuth
Simon Wildermuth
BMBorut Marincek
Borut Marincek
MFMichael Fried
Michael Fried
JDJörg F. Debatin
Jörg F. Debatin
PURPOSE: To assess magnetic resonance (MR) colonography as a method for detection of colorectal masses, with conventional colonoscopy as the reference standard. MATERIALS AND METHODS: MR colonography was performed in 132 patients referred for colonoscopy because of the possible presence of a mass. After rectal filling with a gadopentetate dimeglumine and water enema, T1-weighted three-dimensional gradient-echo MR studies were acquired with the patient in the prone and supine positions. Water-sensitive single-shot fast spin-echo MR images were also obtained. Surface-rendered virtual endoscopic endoluminal views, orthogonal sections in three planes, and water-sensitive MR images were interactively assessed for presence of colorectal masses by two radiologists. RESULTS: MR colonography was well tolerated without sedation or analgesia. MR image quality was sufficient for diagnosis in 127 (96%) patients. Most small (≤5-mm-diameter) masses were overlooked at MR colonography, but 19 of 31 6–10-mm lesions and 26 of 27 large (>10-mm) lesions were correctly identified. For these large masses, MR colonography had a sensitivity of 93%, specificity of 99%, positive predictive value of 92%, and negative predictive value of 98% for detection of masses. CONCLUSION: MR colonography is a promising modality for help in detecting colorectal mass lesions larger than 10 mm in diameter.

1 January 2010 in Patient Safety in Surgery
Verified
Journal Article
Open access
PDF file
TSThomas Steffen
Thomas Steffen
RLRoger Luechinger
Roger Luechinger
SWSimon Wildermuth
Simon Wildermuth
CKChristian Kern
Christian Kern
CFChristian Fretz
Christian Fretz
FHFranc H Hetzer
Franc H Hetzer
Radio Frequency Identification (RFID) devices are becoming more and more essential for patient safety in hospitals. The purpose of this study was to determine patient safety, data reliability and signal loss wearing on skin RFID devices during magnetic resonance imaging (MRI) and computed tomography (CT) scanning.

7 May 1999 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Closed access
WLWolfgang Luboldt
Wolfgang Luboldt
PBPeter Bauerfeind
Peter Bauerfeind
SWSimon Wildermuth
Simon Wildermuth
JDJörg F. Debatin
Jörg F. Debatin

11 May 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
TFTim Fischer
Tim Fischer
YBYassir El Baz
Yassir El Baz
NGNicole Graf
Nicole Graf
SWSimon Wildermuth
Simon Wildermuth
SLSebastian Leschka
Sebastian Leschka
WAWerner C. Albrich
Werner C. Albrich
Background: COVID-19 superinfection by Aspergillus (COVID-19-associated aspergillosis, CAPA) is increasingly observed due to increased awareness and use of corticosteroids. The aim of this study is to compare clinical and imaging features between COVID-19 patients with and without associated pulmonary aspergillosis. Material and Methods: In this case–control study, hospitalized patients between March 2020 and March 2021 were evaluated. Two observers independently compared 105 chest CTs of 52 COVID-19 patients without pulmonary aspergillosis to 40 chest CTs of 13 CAPA patients. The following features were evaluated: lung involvement, predominant main pattern (ground glass opacity, crazy paving, consolidation) and additional lung and chest findings. Chronological changes in the abnormal extent upon CT and chronological changes in the main patterns were compared with mixed models. Patient-wise comparisons of additional features and demographic and clinical data were performed using Student’s t-test, Chi-squared test, Fisher’s exact tests and Wilcoxon rank-sum tests. Results: Compared to COVID-19 patients without pulmonary aspergillosis, CAPA patients were older (mean age (±SD): 70.3 (±7.8) versus 63.5 (±9.5) years (p = 0.01). The time-dependent evolution rates for consolidation (p = 0.02) and ground glass (p = 0.006) differed. In early COVID-19 disease, consolidation was associated with CAPA, whereas ground glass was less common. Chronological changes in the abnormal extent upon CT did not differ (p = 0.29). Regardless of the time point, bronchial wall thickening was observed more frequently in CAPA patients (p = 0.03). Conclusions: CAPA patients showed a tendency for consolidation in early COVID-19 disease. Bronchial wall thickening and higher patient age were associated with CAPA. The overall lung involvement was similar between both groups.

10 June 2020 in Skeletal Radiology
Verified
Journal Article
Closed access
PDF file
ZPZita Passavanti
Zita Passavanti
SLSebastian Leschka
Sebastian Leschka
SWSimon Wildermuth
Simon Wildermuth
TFThomas Forster
Thomas Forster
TDTobias Johannes Dietrich
Tobias Johannes Dietrich

1 January 2006
Verified
Book Chapter
Closed access
PDF file
TKTamás Kovács
Tamás Kovács
PCPhilippe Cattin
Philippe Cattin
Hatem AlkadhiHatem Alkadhi
Hatem Alkadhi
SWSimon Wildermuth
Simon Wildermuth
GSGábor Székely
Gábor Székely